ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,67%
Bitcoin
67 064,51
2,80%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Relay Therapeutics Inc (RLAY)

  7. Relay Therapeutics Inc (RLAY) Actualités

RLAY

Relay Therapeutics (RLAY)

Relay Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:RLAY
DateHeureSourceTitreSymboleSociété
13/05/202414h30GlobeNewswire Inc.Relay Therapeutics to Host New Program and Platform Event on June 6, 2024NASDAQ:RLAYRelay Therapeutics Inc
02/05/202422h05GlobeNewswire Inc.Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
25/04/202422h05GlobeNewswire Inc.Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024NASDAQ:RLAYRelay Therapeutics Inc
11/04/202422h05GlobeNewswire Inc.Relay Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
26/02/202422h05GlobeNewswire Inc.Relay Therapeutics to Participate in Three Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
22/02/202422h34Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RLAYRelay Therapeutics Inc
22/02/202422h16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RLAYRelay Therapeutics Inc
22/02/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLAYRelay Therapeutics Inc
22/02/202422h05GlobeNewswire Inc.Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
15/02/202422h05GlobeNewswire Inc.Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024NASDAQ:RLAYRelay Therapeutics Inc
01/02/202422h05GlobeNewswire Inc.Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:RLAYRelay Therapeutics Inc
31/01/202422h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLAYRelay Therapeutics Inc
10/01/202415h22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:RLAYRelay Therapeutics Inc
10/01/202415h14Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RLAYRelay Therapeutics Inc
08/01/202413h00GlobeNewswire Inc.Relay Therapeutics Announces $30 Million Private Placement FinancingNASDAQ:RLAYRelay Therapeutics Inc
02/01/202422h05GlobeNewswire Inc.Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RLAYRelay Therapeutics Inc
07/11/202322h05GlobeNewswire Inc.Relay Therapeutics to Participate in Stifel 2023 Healthcare ConferenceNASDAQ:RLAYRelay Therapeutics Inc
02/11/202321h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLAYRelay Therapeutics Inc
02/11/202321h05GlobeNewswire Inc.Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
26/10/202322h05GlobeNewswire Inc.Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023NASDAQ:RLAYRelay Therapeutics Inc
12/10/202322h05GlobeNewswire Inc.Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid TumorsNASDAQ:RLAYRelay Therapeutics Inc
18/09/202322h05GlobeNewswire Inc.Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:RLAYRelay Therapeutics Inc
08/08/202322h02GlobeNewswire Inc.Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:RLAYRelay Therapeutics Inc
01/08/202322h05GlobeNewswire Inc.Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023NASDAQ:RLAYRelay Therapeutics Inc
28/06/202323h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RLAYRelay Therapeutics Inc
02/06/202300h22Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:RLAYRelay Therapeutics Inc
31/05/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RLAYRelay Therapeutics Inc
25/05/202323h01GlobeNewswire Inc.Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008NASDAQ:RLAYRelay Therapeutics Inc
24/05/202322h05GlobeNewswire Inc.Relay Therapeutics to Participate in Two Upcoming Investor ConferencesNASDAQ:RLAYRelay Therapeutics Inc
04/05/202322h23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RLAYRelay Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RLAY

Dernières Valeurs Consultées

NASDAQ
TBSAU
TB SA Acquisition
COIN
MILK2ETH
MilkyWay Token by SpaceSwap v2
GATE
WZMUSDT
WooZooMusic
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés